 Home > Active Ingredient News > Anesthesia Topics > U.S. FDA approves new non-opioid dual-acting analgesic Zynrelef

U.S. FDA approves new non-opioid dual-acting analgesic Zynrelef

 Last Update: 2021-05-23
 Source: Internet
 Author: User

Tags

pain management drugs

celebrex dosage pain

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Heron Therapeutics recently announced that the U.

In the first 3 days after surgery, patients usually experience the most severe postoperative pain, and many patients need opioids to control their pain.

In the European Union, Zynrelef was approved in September 2020 for the treatment of postoperative pain caused by small and medium surgical wounds in adults.

It is understood that Zynrelef (HTX-011) is a new, non-opioid analgesic, which is composed of the local anesthetic bupivacaine and the low-dose non-steroidal anti-inflammatory drug meloxicam A dual-acting, fixed-dose combination product, specially designed for a single administration at the surgical site to treat postoperative pain and inflammation.

It is worth mentioning that Zynrelef is the first and only postoperative pain management therapy that has been rigorously tested in the Phase 3 study and proved to be significantly better than bupivacaine solution.

Note: The original text has been deleted

Original source: Heron Therapeutics Announces US FDA approval of ZYNRELEF (HTX-011) for the Management of Postoperative Pain for up to 72 Hours

This article is from Bio Valley, for more information, please download the Bio Valley APP (

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Propofol 2078-54-8 vials safe delivery

CAS No.: 2078-54-8

Pharmacy Grade

$1/G EXW

High quality Propofol CAS NO 2078-54-8

CAS No.: 2078-54-8

Industrial Grade

$1-1.2/KG FOB

Buy Research chemicals online USA|CAS 27767-85-7 | Ro4-1539

CAS No.: 27767-85-7

Industrial Grade

$15-17/G EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.